Harvard Bioscience (HBIO) Misses Q4 EPS by 3c
Tweet
Share
E-mailGet Alerts HBIO Hot Sheet
Price: $6.50 -2.26%
Financial Fact:
Research and development expenses: 1.31M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Research and development expenses: 1.31M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Harvard Bioscience (NASDAQ: HBIO) reported Q4 EPS of $0.02, $0.03 worse than the analyst estimate of $0.05. Revenue for the quarter came in at $25.8 million versus the consensus estimate of $27.15 million.
For earnings history and earnings-related data on Harvard Bioscience (HBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- Aon names interim CFO as Edmund Reese exits the firm
- INVO Fertility (IVF) Tops Q2 EPS by 105c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
